Spectral Analysis of Drug Loaded Nanoparticles for Drug-Polymer Interactions
PLGA [Poly (lactic-co-glycolic acid)] is a one of the widely used biodegradable polymer. The extensive use of PLGA is due to its biocompatible properties and is also approved by FDA and European Medicine Agency in parenteral drug delivery system. Chitosan (CS) is also an extensively used natural polymer in the field of medicine. It has been well documented as a potential drug carrier due to its biocompatibility. Various reports has also suggested the role of chitosan in formulation of nanoparticles to increase the drug bioavailability and efficacy. The characterization of these systems pose interesting analytical challenges. Fourier Transform Infrared (FTIR) technique helps to analyze the adsorption of functional groups on nanoparticles and also to investigate the drug polymer interactions. X-ray powder diffraction (XRD) analysis helps in detection of crystallinity of drugs and polymers on basis of diffraction patterns. This study investigates the characterizations of methotrexate (MTX) and Fluorouracil (5-FU) loaded nanoparticles of PLGA and chitosan with help of FTIR and XRD techniques.
Keywords: PLGA, XRD, MTX, Chitosan, FTIR, 5-FU
2. Bohanec S, Peterka TR, Blazic P, Jurecic R, Grmas J, Krivec A, et al. Using different experimental designs in drug-excipient compatibility studies during the preformulation development of a stable solid dosage formulation. Acta Chim Slov. 2010; 57(4):895-903. PubMed PMID: 24061893.
3. Chidambaram M, Krishnasamy K. Drug-Drug/Drug-Excipient Compatibility Studies on Curcumin using Non-Thermal Methods. Adv Pharm Bull. 2014; 4(3):309-12. PubMed PMID: 24754017. Pubmed Central PMCID: 3992969.
4. Bogdan T, Adriana F, GezaBandurb, EM, Dumitru T. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms. J Pharm Biomed Anal 2011; 56:221– 227.
5. Joshi BV, Patil VB, Pokharkar VB. Compatibility studies between carbamazepine and tablet excipients using thermal and nonthermal methods. Drug Dev Ind Pharm 2002; 28:687–694.
6. Sun SB, Liu P, Shao FM, Miao QL. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer. Int J Clin Exp Med. 2015; 8(10):19670-81. PubMed PMID: 26770631.
7. Reznik D, Olk CH, Neumann DA, Copley JR. X-ray powder diffraction from carbon nanotubes and nanoparticles. Phys Rev B Condens Matter. 1995; 52(1):116-24. PubMed PMID: 9979582.
8. Yang, S. C., Lu, L. F., Cai, Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 1997; 14(10):1431-6. PubMed PMID: 9358557
9. Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm. 2007 May 24; 336(2):367-75. PubMed PMID: 17207944.
10. Rachmawati H, Yanda YL, Rahma A, Mase N. Curcumin-Loaded PLA Nanoparticles: Formulation and Physical Evaluation. Sci Pharm. 2016; 84(1):191-202. PubMed PMID: 27110509. Pubmed Central PMCID: 4839549.
11. Lin PC, Lin S, Wang PC, Sridhar R. Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv. 2014; 32(4):711-26. PubMed PMID: 24252561. Pubmed Central PMCID: 4024087.
12. Krishna Rao KSV, Vijaya Kumar Naidu B, Subha MCS, Sairam M, Aminabhavi TM. Novel chitosan-based pH-sensitive interpenetrating network microgels for the controlled release of cefadroxil. Carbohydrate Polymers. 2006; 66(3):333-44.
13. De Souza Costa-Junior E, Pereira MM, Mansur HS. Properties and biocompatibility of chitosan films modified by blending with PVA and chemically crosslinked. J Mater Sci Mater Med. 2009; 20(2):553-61. PubMed PMID: 18987949.
14. Singh G, Kaur T, Kaur R, Kaur A. Recent biomedical applications and patents on biodegradable polymer-PLGA. Int J Pharmacol Pharm Sci. 2014; 1(2):30-32
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).